Fifty Years, Yes VC, Y Combinator, Starlight Ventures, The Venture Collective, SGH Capital, Milano Investment Partners
Company Traction
As of June 2023, HelixNano was working towards moving a variant-resistant COVID-19 vaccine candidate toward clinical trials.
Leadership Team
Hannu Rajaniemi: Co-Founder & CEO of HelixNano. Former Co-Founder of ThinkTank Maths.
Nikolai Eroshenko: Co-Founder & Chief Science Officer of HelixNano. Former Postdoctoral Research Associate at Harvard Medical School.
Julia Carvalho: COO at HelixNano. Former Special Projects at Wave.
Marianna Keaveney: Director of Clinical Product Development at HelixNano.
Nicole Brellenthin: Head of Operations at HelixNano. Former Senior Manager, Administrative Operations and Special Projects at Broad Institute of MIT and Harvard.
